AI assistant
Sending…
Microbot Medical Inc. — Director's Dealing 2014
Jun 18, 2014
33819_dirs_2014-06-18_b2934e5a-1975-4001-83c8-049906fbd7de.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STEMCELLS INC (STEM)
CIK: 0000883975
Period of Report: 2014-06-16
Reporting Person: MCGLYNN MARTIN M (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-06-16 | Common Stock | F | 99883 | $1.52 | Disposed | 1018891 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 22030 | Indirect |
Footnotes
F1: This is recorded as a code F disposition because the shares were used by the reporting person to pay a tax liability incurred by him for the delivery of the shares incident to the vesting of restricted stock units
F2: Includes (1) 525,000 restricted stock units, with 175,000 of those vesting on each of June 14, 2015, June 14, 2016, and June 14, 2017; and (2) 135,333 restrictd stock units vesting on January 27, 2015.
F3: Shares held in 401(k) account, in accordance with issuer's employer-match policies.
More from Microbot Medical Inc.
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 5
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 22
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 13
Regulatory Filings
2026
Apr 10